Jefferies Financial Group Lowers Evotec (NASDAQ:EVO) to Hold

Jefferies Financial Group cut shares of Evotec (NASDAQ:EVO – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage currently has $3.80 target price on the stock, down from their prior target price of $8.70. Several other research firms have also […]

Leave a Reply

Your email address will not be published.

Previous post UBS Group Begins Coverage on Clover Health Investments (NASDAQ:CLOV)
Next post AMN Healthcare Services (NYSE:AMN) Cut to Underperform at Bank of America